$356 Million is the total value of Ghost Tree Capital, LLC's 44 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $12,159,000 | +24.8% | 110,000 | -15.4% | 3.41% | -32.8% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $10,973,000 | +58.1% | 535,000 | -10.8% | 3.08% | -14.8% |
| COGT | Sell | COGENT BIOSCIENCES INC | $8,952,000 | +10.3% | 600,000 | -33.3% | 2.51% | -40.6% |
| ISEE | Sell | IVERIC BIO INC | $8,319,000 | +73.0% | 463,700 | -7.3% | 2.34% | -6.8% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $6,748,000 | +18.5% | 30,000 | -33.3% | 1.89% | -36.1% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $5,220,000 | -51.4% | 500,000 | -50.0% | 1.46% | -73.8% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $4,806,000 | +11.0% | 200,000 | -11.1% | 1.35% | -40.2% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $4,642,000 | -41.8% | 75,000 | -25.0% | 1.30% | -68.6% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $2,165,000 | -28.1% | 90,000 | -45.5% | 0.61% | -61.2% |
| DSGN | Sell | DESIGN THERAPEUTICS INC | $1,672,000 | -56.6% | 100,000 | -63.6% | 0.47% | -76.6% |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -1,900 | -100.0% | -0.14% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.24% | – | |
| NMTR | Exit | 9 METERS BIOPHARMA INC | $0 | – | -1,800,000 | -100.0% | -0.24% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -50,000 | -100.0% | -1.93% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -110,000 | -100.0% | -2.41% | – |
| MRUS | Exit | MERUS N V | $0 | – | -250,000 | -100.0% | -2.95% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -35,000 | -100.0% | -3.23% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEWcall | $0 | – | -400,000 | -100.0% | -5.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.